MedTrace Logo

Identification of Pathophysiological Pathways and Therapeutic Targets in Primary Stomatodynia by Salivary Metabolomics

NCT04704128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2021-07-07

No results posted yet for this study

Summary

Burning mouth syndrome (BMS) is defined by a chronic oral pain affecting especially postmenopausal women. Its physiopathology is still unknown and several hypotheses have been put forward to explain this syndrome, such as neurological, hormonal or inflammatory process. The recent development of salivary metabolomic profiling in oral diseases has led to the identification of potential pathways in such disorders. The aim of this study is to analyze the salivary metabolomic in BMS patients compared to healthy controls.

Conditions

  • Primary Burning Mouth Syndrome

Interventions

OTHER

Salivic sample

Collection of total saliva not stimulated

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Mahtab SAMIMI, MD-PhD · University Hospital, Tours

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-10
Primary Completion
2021-05-12
Completion
2021-05-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04704128 on ClinicalTrials.gov